Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme

scientific article

Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1006/JMBI.1994.1655
P698PubMed publication ID7932756

P2093author name stringS Chakravarty
K K Kannan
P433issue2
P304page(s)298-309
P577publication date1994-10-21
P1433published inJournal of Molecular BiologyQ925779
P1476titleDrug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme
P478volume243

Reverse relations

cites work (P2860)
Q37108161Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding
Q58863352Carbonic anhydrase inhibitors — Part 53. Synthesis of substituted-pyridinium derivatives of aromatic sulfonamides: The first non-polymeric membrane-impermeable inhibitors with selectivity for isozyme IV
Q43597329Characterisation of carbonic anhydrase in Plasmodium falciparum
Q28513669Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family
Q30362527Competitive inhibitory effects of acetazolamide upon interactions with bovine carbonic anhydrase II.
Q57909187Crystal analysis of aromatic sulfonamide binding to native and (Zn)2 adduct of human carbonic anhydrase I Michigan 1
Q27637428Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulphamate
Q35748554DOCK 6: Impact of new features and current docking performance
Q40744359Docking of sulfonamides to carbonic anhydrase II and IV.
Q27664009High-Resolution Crystal Structure of the Subclass B3 Metallo- -Lactamase BJP-1: Rational Basis for Substrate Specificity and Interaction with Sulfonamides
Q54327473How Diverse Are the Protein-Bound Conformations of Small-Molecule Drugs and Cofactors?
Q34660349Malaria parasite carbonic anhydrase: inhibition of aromatic/heterocyclic sulfonamides and its therapeutic potential
Q34775956Metallotherapeutics: novel strategies in drug design
Q90332719Network of Conformational Transitions Revealed by Molecular Dynamics Simulations of the Carbonic Anhydrase II Apo-Enzyme
Q27733462Novel active site in Escherichia coli fructose 1,6-bisphosphate aldolase
Q54567997Novel aromatic/heterocyclic sulfonamides and their metal complexes as inhibitors of carbonic anhydrase isozymes I, II and IV.
Q48110370Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases.
Q57974657SEVERAL COORDINATION MODES OF 5-AMINO-1,3,4-THIADIAZOLE-2-SULFONAMIDE (HATS) WITH Cu(II), Ni(II) AND Zn(II): MIMETIC TERNARY COMPLEXES OF CARBONIC ANHYDRASE-INHIBITOR
Q27676150Structural Studies of β-Carbonic Anhydrase from the Green Alga Coccomyxa: Inhibitor Complexes with Anions and Acetazolamide
Q59020949Structural and Vibrational Study on Monomer and Dimer Forms and Water Clusters of Acetazolamide
Q28111928Structure and mechanism of carbonic anhydrase
Q92623157Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design
Q46065351Tritium NMR studies of the human carbonic anhydrase I-benzenesulfonamide complex

Search more.